1 year return (CAGR)
107.02%
Neurosense Therapeutics Ltd Exchange (NASDAQ, USD)
NRSN
1.99
-0.01 (-0.42%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
70.40%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
4.48M
Price/Sales
-
Ent value
6.90M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
11.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.33 |
| Daily high | 2.37 |
| Daily low | 2.20 |
| Daily Volume | 17K |
| All-time high | 8.02 |
| 1y analyst estimate | 97.33 |
| Beta | 1.58 |
| EPS (TTM) | -0.20 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NRSN | S&P500 | |
| Current price drop from All-time high | -75.19% | -3.00% |
| Highest price drop | -94.38% | -56.47% |
| Date of highest drop | 20 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -75.71% | -10.65% |
| Avg time to new high | 245 days | 12 days |
| Max time to new high | 1121 days | 1805 days |
News
